Dr. Melinda Irwin, professor chronic disease epidemiology at the Yale School of Public Health, has been named a Fellow in the 2017-2018 Class of the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Program for Women. Established in 1995, the program offers an intensive one-year fellowship of leadership training with extensive coaching, networking and mentoring opportunities aimed at expanding the national pool of qualified women candidates for leadership in academic medicine, dentistry and public health.
[Photo: Dr. Melinda Irwin]
In addition to her teaching and research, Dr. Irwin serves as associate director (population sciences) in the Yale Cancer Center, co-program leader of the Cancer Prevention and Control Research Program at Yale Cancer Center, and deputy director for public in the Yale Center for Clinical Investigation.
Dr. Irwin is a prominent leader in the field of lifestyle factors and chronic diseases. Her research over the past 15 years has focused on randomized trials of exercise and weight loss on biological markers, treatment side effects and quality of life in cancer patients and survivors. She has received funding from the NIH, ACS, American Institute for Cancer Research, Komen for the Cure, Livestrong Foundation and other foundations and has published her research findings in top medical journals. For the past 10 years, Dr. Irwin has been the Director of Training and Education on the NCI-Transdisciplinary Research on Energetics and Cancer (TREC) Initiative. At Yale, Dr. Irwin has advised, mentored and trained over 100 trainees on public health related studies. Dr. Irwin also serves on various national advisory committees to develop consensus statements on physical activity, diet, weight and cancer prevention and control.